Melinta Therapeutics Inc (MLNTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,676 | -69,956 | -42,386 | -17,416 | -61,649 |
| Depreciation Amortization | 624 | 459 | 411 | 202 | 844 |
| Accounts receivable | -228 | -748 | -1,344 | -11,868 | -724 |
| Accounts payable and accrued liabilities | -2,874 | 3,025 | 1,860 | -1,042 | 5,620 |
| Other Working Capital | 3,321 | 5,405 | 1,809 | -13,550 | 8,728 |
| Other Operating Activity | 5,279 | 2,303 | 2,345 | 14,345 | -1,911 |
| Operating Cash Flow | $-72,554 | $-59,512 | $-37,305 | $-29,329 | $-49,092 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -688 | -46 | -46 | -46 | -52 |
| Investing Cash Flow | $-688 | $-46 | $-46 | $-46 | $-52 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 20,000 | N/A | N/A | 3,000 |
| Debt Repayment | N/A | -18,995 | -443 | N/A | N/A |
| Common Stock Issued | 365 | 141,997 | 141,302 | 139,593 | 48,886 |
| Other Financing Activity | 82,494 | -540 | -213 | -213 | -132 |
| Financing Cash Flow | $92,859 | $142,462 | $140,646 | $139,380 | $51,754 |
| Beginning Cash Position | 10,541 | 99,113 | 99,113 | 99,113 | 96,503 |
| End Cash Position | 30,158 | 182,017 | 202,408 | 209,118 | 99,113 |
| Net Cash Flow | $19,617 | $82,904 | $103,295 | $110,005 | $2,610 |
| Free Cash Flow | |||||
| Operating Cash Flow | -72,554 | -59,512 | -37,305 | -29,329 | -49,092 |
| Capital Expenditure | -688 | -46 | -46 | -46 | -52 |
| Free Cash Flow | -73,242 | -59,558 | -37,351 | -29,375 | -49,144 |